Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce mortality
and cardiovascular morbidity among patients with myocardial infarction complicated by …

Background The optimal combination drug therapy for hypertension is not established,
although current US guidelines recommend inclusion of a diuretic. We hypothesized that …

Background The presence of coexisting conditions has a substantial effect on the outcome of
acute myocardial infarction. Renal failure is associated with one of the highest risks, but the …

Background Loop diuretics are an essential component of therapy for patients with acute
decompensated heart failure, but there are few prospective data to guide their use. Methods In …

Background Many patients have symptoms suggestive of coronary artery disease (CAD) and
are often evaluated with the use of diagnostic testing, although there are limited data from …

2D (Two-dimensional), 3C (Three-chamber (apical long axis)), 3D (Three-dimensional), 4C (Four-chamber),
5C (Five-chamber), A2C (Apical two-chamber), A4C (Apical four-chamber), …

Background The role of coronary-artery bypass grafting (CABG) in the treatment of patients
with coronary artery disease and heart failure has not been clearly established. Methods …

Importance Studies in experimental and human heart failure suggest that phosphodiesterase-5
inhibitors may enhance cardiovascular function and thus exercise capacity in heart …

Background Ultrafiltration is an alternative strategy to diuretic therapy for the treatment of
patients with acute decompensated heart failure. Little is known about the efficacy and safety of …

Background Acute decompensated heart failure accounts for more than 1 million hospitalizations
in the United States annually. Whether the initiation of sacubitril–valsartan therapy is …